Single-Cell Dissection of Sarcomas Reveals Therapeutic Vulnerabilities in Cancer Cells and Their Microenvironment
Thursday, January 28, 2027 at 2:10 PM to 2:40 PM · 30 min. (Europe/London)
Single-Cell Stage
Day 2 - Thursday 28th January
CancerSingle-Cell
Information
- Liposarcomas (LPS) are rare, heterogenous and malignant tumours. LPS progression mechanisms are poorly understood, and current understanding of the immune, fibroblast and endothelial populations in the tumour microenvironment remains limited.
- We conducted a comprehensive assessment of single-cell RNAseq of Liposarcoma samples which highlighted transcriptionally distinct cell clusters, and varying functional roles that reflect on differences in tumour aggressiveness, invasion and plasticity.
- Analysis of cell-cell communication and copy number status also identified unique signaling patterns for tumour cells and non-tumour cell populations that present routes for targeted therapy.
- Overall, our analysis identified multiple avenues that can be used for profiling Liposarcoma towards stratified treatment.
